is tirzepatide the same as glp-1 Associated with Lower POAG, OHT Risk Compared with Other Drugs The Science Behind Tirzepatide: GLP-1

Clinical trials and real-world data show that weight regain is common when patients stop taking GLP-1 drugs

Call 999 or go to A&E immediately if headache is accompanied by: Severe, sudden-onset headache (often described as "thunderclap" or the worst headache ever experienced) Neurological symptoms such as visual disturbances, weakness, numbness, difficulty speaking, or confusion Persistent vomiting that prevents adequate fluid or medication intake Signs of severe hypoglycaemia including sweating, tremor, palpitations, or altered consciousness Fever, neck stiffness, or photophobia , which may indicate serious infection If you suspect pancreatitis (severe, persistent abdominal pain, often radiating to the back, with or without vomiting), stop taking your GLP-1 medication and seek urgent medical attention

3.3.3 Long-acting release formulation of exenatide (Microspheres) Polymer materials commonly used in microsphere preparation are polylactic-co-glycolic acid (PLGA), which is approved by FDA and has good safety and biodegradability

The slow titration concern is worth investigating before signing up